PPA
KNSA icon

Parametric Portfolio Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Parametric Portfolio Associates’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.14M Sell
114,766
-34,989
-23% -$371K ﹤0.01% 2721
2021
Q4 		$1.76M Buy
149,755
+79,609
+113% +$978K ﹤0.01% 2509
2021
Q3 		$799K Buy
70,146
+4,558
+7% +$59.4K ﹤0.01% 2898
2021
Q2 		$914K Sell
65,588
-6,555
-9% -$99.6K ﹤0.01% 2813
2021
Q1 		$1.33M Buy
72,143
+4,974
+7% +$102K ﹤0.01% 3025
2020
Q4 		$1.19M Buy
67,169
+30,913
+85% +$543K ﹤0.01% 2958
2020
Q3 		$555K Buy
36,256
+3,222
+10% +$60.5K ﹤0.01% 3222
2020
Q2 		$842K Sell
33,034
-7,498
-18% -$157K ﹤0.01% 3008
2020
Q1 		$627K Sell
40,532
-18,325
-31% -$287K ﹤0.01% 3041
2019
Q4 		$651K Buy
58,857
+7,285
+14% +$63.3K ﹤0.01% 3269
2019
Q3 		$439K Buy
51,572
+19,977
+63% +$221K ﹤0.01% 3389
2019
Q2 		$428K Buy
31,595
+4,787
+18% +$74.3K ﹤0.01% 3423
2019
Q1 		$484K Buy
26,808
+4,243
+19% +$82K ﹤0.01% 3353
2018
Q4 		$634K Sell
22,565
-1,357
-6% -$28.3K ﹤0.01% 3208
2018
Q3 		$610K Buy
23,922
+7,218
+43% +$140K ﹤0.01% 3335
2018
Q2 		$290K Buy
+16,704
New +$302K ﹤0.01% 3566

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parametric Portfolio Associates's KNSA Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Kiniksa Pharmaceuticals (KNSA) stake by 23% in Q1 2022, selling an estimated $371K and leaving 114,766 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

Parametric Portfolio Associates first reported a position in KNSA in Q2 2018 and has held it in 16 quarters since. The position peaked at $1.76M in Q4 2021. 96 funds tracked by Wall St. Rank hold KNSA as of Q1 2022.

  • Parametric Portfolio Associates held 114,766 shares of Kiniksa Pharmaceuticals worth $1.14M as of Q1 2022.
  • Parametric Portfolio Associates sold 34,989 Kiniksa Pharmaceuticals shares in Q1 2022, an estimated $371K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2721 holding.
  • Parametric Portfolio Associates first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and has held it in 16 quarters since.
  • Parametric Portfolio Associates's Kiniksa Pharmaceuticals position peaked at $1.76M in Q4 2021.
  • 96 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.